Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
15.51
-0.36 (-2.27%)
Sep 23, 2026, 11:28 AM EDT - Market open

AAPG Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, AAPG stock has a consensus rating of "Strong Buy" and an average price target of $47.13. The average 1-year stock price forecast is 203.87% higher than the current stock price, while the lowest is $40 (+157.90%) and the highest is $55 (+254.61%).

Price Target: $47.13 (+203.87%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$40$47.13$46.5$55
Change+157.90%+203.87%+199.81%+254.61%

Analyst Ratings

The average analyst rating for AAPG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy566776
Buy222222
Hold000000
Sell000000
Strong Sell000000
Total788998

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
B. Riley Securities
B. Riley Securities
Buy
Maintains
$45
BuyMaintains$45+190.14%Sep 2, 2026
BTIG
BTIG
Buy
Maintains
$48
BuyMaintains$48+209.48%Aug 21, 2026
Truist Financial
Truist Financial
Buy
Maintains
n/a
BuyMaintainsn/an/aAug 21, 2026
Oppenheimer
Oppenheimer
Buy
Maintains
$45
BuyMaintains$45+190.14%Aug 21, 2026
Piper Sandler
Piper Sandler
Buy
Maintains
$48
BuyMaintains$48+209.48%Jun 1, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
696.83M
from 574.12M
Increased by 21.37%
Revenue Next Year
1.48B
from 696.83M
Increased by 112.93%
EPS This Year
-3.93
from -3.49
EPS Next Year
-0.33
from -3.93
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
27.91M209.71M221.98M980.65M574.12M696.83M
Revenue Growth
124.18%651.38%5.85%341.77%-41.46%21.37%
Gross Profit
24.58M187.71M191.44M951.57M525.18M658.15M
Gross Margin
88.08%89.51%86.24%97.03%91.48%94.45%
Operating Income
-933.17M-883.41M-891.99M-378.80M-1.21B-1.49B
Net Income
-782.42M-882.92M-925.64M-405.43M-1.24B-1.54B
EPS
-----3.49-3.93
Free Cash Flow
-----1.20B-1.59B
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High879.4M
Avg696.8M
Low614.1M

Revenue Growth

Revenue Growth202620272028
High
53.2%
Avg
21.4%
Low
7.0%

EPS Forecast

EPS202620272028
High-3.84
Avg-3.93
Low-4.03

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-